Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

Maria Teresa Pallotta(University of Perugia), Ciriana Orabona(University of Perugia), Claudia Volpi(University of Perugia), Carmine Vacca(University of Perugia), Maria Laura Belladonna(University of Perugia), Roberta Bianchi(University of Perugia), Giuseppe Servillo(University of Perugia), Cinzia Brunacci(University of Perugia), Mario Calvitti(University of Perugia), Silvio Bicciato(University of Modena and Reggio Emilia), Emilia Maria Cristina Mazza(University of Modena and Reggio Emilia), Louis Boon(Polpharma Biologics (Netherlands)), Fabio Grassi, Maria C. Fioretti(University of Perugia), Francesca Fallarino(University of Perugia), Paolo Puccetti(University of Perugia), Ursula Grohmann(University of Perugia)
Nature Immunology
July 31, 2011
Cited by 689Open Access
Full Text

Abstract

The tryptophan-catalytic activity of IDO in dendritic cells is known to regulate immune responses. Grohmann and co-workers show that IDO also functions as an intracellular signal transducer in response to transforming growth factor-β. Regulation of tryptophan metabolism by indoleamine 2,3-dioxygenase (IDO) in dendritic cells (DCs) is a highly versatile modulator of immunity. In inflammation, interferon-γ is the main inducer of IDO for the prevention of hyperinflammatory responses, yet IDO is also responsible for self-tolerance effects in the longer term. Here we show that treatment of mouse plasmacytoid DCs (pDCs) with transforming growth factor-β (TGF-β) conferred regulatory effects on IDO that were mechanistically separable from its enzymic activity. We found that IDO was involved in intracellular signaling events responsible for the self-amplification and maintenance of a stably regulatory phenotype in pDCs. Thus, IDO has a tonic, nonenzymic function that contributes to TGF-β-driven tolerance in noninflammatory contexts.


Related Papers

No related papers found

Powered by citation graph analysis